Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.53B |
| 3 |
Amazon
AMZN
|
+$1.11B |
| 4 |
Airbnb
ABNB
|
+$574M |
| 5 |
NVIDIA
NVDA
|
+$519M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$588M |
| 2 |
NIO
NIO
|
+$539M |
| 3 |
Apple
AAPL
|
+$525M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$443M |
| 5 |
Microsoft
MSFT
|
+$375M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.77% |
| 2 | Consumer Discretionary | 1.94% |
| 3 | Technology | 1.9% |
| 4 | Communication Services | 1.42% |
| 5 | Financials | 1.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4151
CALL
Silicon Laboratories
SLAB
$7.29B
| $4.52M | ﹤0.01% |
29,500
+11,400
| +63% | +$1.59M |
|
4152
BorgWarner
BWA
$13.1B
| $4.52M | ﹤0.01% |
105,776
+10,861
| +11% | +$478K |
|
4153
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.08B
| $4.52M | ﹤0.01% |
34,054
-25,721
| -43% | -$3.35M |
|
4154
CALL
Direxion Daily Retail Bull 3X ETF
RETL
$25.7M
| $4.51M | ﹤0.01% |
93,000
+54,500
| +142% | +$2.39M |
|
|
LBJ
4155
DELISTED
Direxion Daily Latin America Bull 2X Shares
LBJ
| $4.51M | ﹤0.01% |
50,034
+10,454
| +26% | +$847K |
|
4156
IonQ
IONQ
$15.9B
| $4.51M | ﹤0.01% |
422,065
+304,125
| +258% | +$3.15M |
|
4157
Textron
TXT
$14.3B
| $4.51M | ﹤0.01% |
65,524
+12,065
| +23% | +$780K |
|
4158
PUT
Western Alliance Bancorporation
WAL
$8.57B
| $4.5M | ﹤0.01% |
48,500
+22,300
| +85% | +$2.21M |
|
4159
PUT
Ouster
OUST
$2.5B
| $4.5M | ﹤0.01% |
36,010
+17,630
| +96% | +$1.88M |
|
4160
PUT
DigitalOcean
DOCN
$13.1B
| $4.5M | ﹤0.01% |
+80,900
| New | +$3.49M |
|
4161
BlueLinx
BXC
$624M
| $4.5M | ﹤0.01% |
89,429
+20,161
| +29% | +$992K |
|
|
ME
4162
PUT
DELISTED
23andMe Holding Co
ME
| $4.49M | ﹤0.01% |
19,220
+1,045
| +6% | +$218K |
|
4163
CALL
Ingles Markets
IMKTA
$1.56B
| $4.49M | ﹤0.01% |
77,100
+20,700
| +37% | +$1.28M |
|
4164
MidCap Financial Investment
MFIC
$792M
| $4.49M | ﹤0.01% |
329,083
-301,637
| -48% | -$4.32M |
|
4165
PUT
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24B
| $4.49M | ﹤0.01% |
15,500
-46,200
| -75% | -$12.9M |
|
|
4166
CALL
BlueLinx
BXC
$624M
| $4.49M | ﹤0.01% |
89,300
+57,300
| +179% | +$2.82M |
|
4167
Buckle
BKE
$2.24B
| $4.48M | ﹤0.01% |
90,085
+69,275
| +333% | +$2.94M |
|
4168
CALL
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.88B
| $4.48M | ﹤0.01% |
47,400
+23,300
| +97% | +$2.18M |
|
4169
Coherent
COHR
$54.7B
| $4.48M | ﹤0.01% |
61,710
+24,191
| +64% | +$1.7M |
|
4170
PUT
BioXcel Therapeutics
BTAI
$5.68M
| $4.47M | ﹤0.01% |
9,625
+5,225
| +119% | +$2.85M |
|
4171
CALL
Manulife Financial
MFC
$70.9B
| $4.47M | ﹤0.01% |
227,000
-255,400
| -53% | -$5.35M |
|
4172
Freshpet
FRPT
$3.4B
| $4.47M | ﹤0.01% |
27,418
-5,883
| -18% | -$1M |
|
4173
PUT
PACCAR
PCAR
$66B
| $4.46M | ﹤0.01% |
75,000
+47,550
| +173% | +$2.91M |
|
4174
CALL
Marriott Vacations Worldwide
VAC
$3.79B
| $4.46M | ﹤0.01% |
28,000
-1,400
| -5% | -$240K |
|
4175
iShares S&P 500 Value ETF
IVE
$50.2B
| $4.46M | ﹤0.01% |
30,185
+28,175
| +1,402% | +$4.15M |
|
Similar funds
Jeff Yass's Q2 2021 Portfolio in Review
As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 91% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
- Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
- Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
- Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
- Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
- Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
- Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.
Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.